J0490 Belimumab injection
Also known as: belimumab, Benlysta
Belimumab injection, a B-lymphocyte stimulator inhibitor for systemic lupus erythematosus.
In Plain Language
lupus treatment injection; autoimmune disease therapy
Clinical Context
Intravenous monoclonal antibody against B-lymphocyte stimulator (BLyS) for moderate-to-severe systemic lupus erythematosus. Reduces lupus activity.
RVU Information
CPT J0490 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0490?
CPT J0490 (Belimumab injection) is a J Codes (Drugs) code. Belimumab injection, a B-lymphocyte stimulator inhibitor for systemic lupus erythematosus.
How is J0490 administered?
CPT J0490 is administered by a healthcare provider, typically via injection or infusion. Intravenous monoclonal antibody against B-lymphocyte stimulator (BLyS) for moderate-to-severe systemic lupus erythematosus. Reduces lupus activity. It is used by Rheumatology, Internal Medicine, Immunology.
When is CPT J0490 used?
Intravenous monoclonal antibody against B-lymphocyte stimulator (BLyS) for moderate-to-severe systemic lupus erythematosus. Reduces lupus activity.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.